BDX Share Price

Open 166.47 Change Price %
High 167.08 1 Day -1.12 -0.68
Low 163.93 1 Week -8.32 -4.82
Close 164.41 1 Month -10.58 -6.05
Volume 1597996 1 Year 9.60 6.20
52 Week High 181.76
52 Week Low 129.50
BDX Important Levels
Resistance 2 167.33
Resistance 1 166.13
Pivot 165.14
Support 1 162.69
Support 2 161.49
NYSE USA Most Active Stocks
BAC 21.84 2.87%
BAC 21.84 2.87%
BAC 21.84 2.87%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
CHK 7.48 3.46%
More..
NYSE USA Top Gainers Stocks
VNR 1.34 47.25%
VNR 1.34 47.25%
BCEI 1.47 27.83%
POM 26.93 26.79%
POM 26.93 26.79%
TDW 3.21 22.05%
TDW 3.21 22.05%
TDW 3.21 22.05%
UTI 3.07 17.18%
UTI 3.07 17.18%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Becton, Dickinson and Company (NYSE: BDX)

BDX Technical Analysis 2
As on 5th Dec 2016 BDX Share Price closed @ 164.41 and we RECOMMEND Buy for LONG-TERM with Stoploss of 163.64 & Strong Sell for SHORT-TERM with Stoploss of 172.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
BDX Target for December
1st Target up-side 178.58
2nd Target up-side 185.22
3rd Target up-side 191.86
1st Target down-side 159.62
2nd Target down-side 152.98
3rd Target down-side 146.34
BDX Other Details
Segment EQ
Market Capital 15659074560.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.bd.com
BDX Address
BDX
1 Becton Drive
Franklin Lakes, NJ 07417
United States
Phone: 201-847-6800
Interactive Technical Analysis Chart Becton, Dickinson and Company ( BDX NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Becton, Dickinson and Company
BDX Business Profile
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment produces medical devices that are used in various healthcare settings. This segment’s products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; and generic prefilled injectables. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment’s products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company’s BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment’s products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.